• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类血管活性肠肽1型受体(VPAC1)中谷氨酸的可磷酸化残基苏氨酸429发生突变,导致受体持续脱敏。

Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptor.

作者信息

Langlet Christelle, Nachtergael Ingrid, Robberecht Patrick, Langer Ingrid

机构信息

Laboratoire de Chimie Biologique et de la Nutrition, School of Medicine, Université Libre de Bruxelles, 808 Route de Lennik-CP611, B-1070 Bruxelles, Belgium.

出版信息

Peptides. 2006 Jul;27(7):1865-70. doi: 10.1016/j.peptides.2006.01.010. Epub 2006 Mar 22.

DOI:10.1016/j.peptides.2006.01.010
PMID:16554109
Abstract

The hVPAC1 receptor is rapidly phosphorylated and internalized by agonists but not re-expressed at the membrane after washing. Mutation of Ser/Thr residues in the C-terminus reduced phosphorylation but not internalization that was abolished only when all the phosphorylatable residues were mutated. Substitution of Thr429 by Glu mimicking a phosphothreonin led to a mutant with unchanged binding properties, decreased coupling to adenylate cyclase consisting in a reduced VIP potency, increased basal and VIP stimulated phosphorylation, preserved internalization followed by a rapid receptor re-expression. These are the expected characteristics of a constitutively desensitized receptor, putting forward the role of Thr429 phosphorylation in that process.

摘要

hVPAC1受体可被激动剂迅速磷酸化并内化,但洗涤后不会在细胞膜上重新表达。C末端的丝氨酸/苏氨酸残基发生突变会降低磷酸化,但不会影响内化,只有当所有可磷酸化残基都发生突变时,内化才会被消除。将苏氨酸429替换为模拟磷酸苏氨酸的谷氨酸会产生一个突变体,其结合特性不变,与腺苷酸环化酶的偶联减少,表现为VIP效力降低,基础磷酸化和VIP刺激的磷酸化增加,内化得以保留,随后受体快速重新表达。这些是组成型脱敏受体的预期特征,表明苏氨酸429磷酸化在该过程中的作用。

相似文献

1
Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptor.人类血管活性肠肽1型受体(VPAC1)中谷氨酸的可磷酸化残基苏氨酸429发生突变,导致受体持续脱敏。
Peptides. 2006 Jul;27(7):1865-70. doi: 10.1016/j.peptides.2006.01.010. Epub 2006 Mar 22.
2
Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.VPAC1受体第三螺旋中的Asn229对于受体激活至关重要,但对于受体磷酸化和内化并非必需:与VPAC2受体中的Asn216进行比较。
Cell Signal. 2006 Dec;18(12):2121-30. doi: 10.1016/j.cellsig.2006.03.006. Epub 2006 Mar 27.
3
Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.人VPAC1受体羧基末端的丝氨酸447对激动剂诱导的脱敏至关重要,但对受体的内化并不重要。
Mol Pharmacol. 2003 Dec;64(6):1565-74. doi: 10.1124/mol.64.6.1565.
4
Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.失活突变对人VPAC2受体磷酸化及内化的影响。
J Mol Endocrinol. 2005 Apr;34(2):405-14. doi: 10.1677/jme.1.01717.
5
Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation.人重组VPAC1受体第三个细胞内环羧基末端的突变会损害血管活性肠肽(VIP)刺激的细胞内钙离子浓度([Ca2+]i)升高,但不会损害腺苷酸环化酶的刺激作用。
Cell Signal. 2005 Jan;17(1):17-24. doi: 10.1016/j.cellsig.2004.05.009.
6
Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling.VPAC1受体羧基末端对激动剂诱导的受体磷酸化、内化和再循环的作用。
J Biol Chem. 2005 Jul 29;280(30):28034-43. doi: 10.1074/jbc.M500449200. Epub 2005 Jun 2.
7
Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.
Ann N Y Acad Sci. 2006 Jul;1070:180-4. doi: 10.1196/annals.1317.009.
8
Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.乙酰组氨酸1 [D-苯丙氨酸2、赖氨酸15、精氨酸16、亮氨酸27] 血管活性肠肽 (3-7)/生长激素释放因子 (8-27)——一种VPAC1受体拮抗剂——对两种组成型活性截短型VPAC1受体起反向激动剂作用。
Peptides. 2004 Nov;25(11):1943-9. doi: 10.1016/j.peptides.2004.06.001.
9
Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).共表达两种血管活性肠肽受体(hVPAC1和hVPAC2)的中国仓鼠卵巢细胞的药理学特性
Br J Pharmacol. 2006 Aug;148(8):1051-9. doi: 10.1038/sj.bjp.0706816. Epub 2006 Jun 19.
10
Characterization of the new photoaffinity probe (Bz2-K24)-VIP.
Ann N Y Acad Sci. 2006 Jul;1070:575-80. doi: 10.1196/annals.1317.084.